[1]梁燕茹,郑 瑜,李 倩.子宫内膜癌患者术前血清apo AI 和Apelin 水平检测对预测淋巴脉管间隙浸润风险的价值研究[J].现代检验医学杂志,2023,38(05):53-57+85.[doi:10.3969/j.issn.1671-7414.2023.05.010]
　LIANG Yanru,ZHENG Yu,LI Qian.Value of Preoperative Serum Apo AI and Apelin Levels in Predicting the Risk of Lymph Node Vascular Space Infiltration in Patients with Endometrial Cancer[J].Journal of Modern Laboratory Medicine,2023,38(05):53-57+85.[doi:10.3969/j.issn.1671-7414.2023.05.010]
点击复制

子宫内膜癌患者术前血清apo AI 和Apelin 水平检测对预测淋巴脉管间隙浸润风险的价值研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年05期
页码:
53-57+85
栏目:
论著
出版日期:
2023-09-15

文章信息/Info

Title:
Value of Preoperative Serum Apo AI and Apelin Levels in Predicting the Risk of Lymph Node Vascular Space Infiltration in Patients with Endometrial Cancer
文章编号:
1671-7414（2023）05-053-06
作者:
梁燕茹1; 郑 瑜1; 李 倩2
（1. 石家庄市妇幼保健院妇产科，石家庄 050000；2. 保定市妇幼保健院妇产科，河北保定 071000）
Author(s):
LIANG Yanru1;  ZHENG Yu1;  LI Qian2
（1. Department of Obstetrics and Gynecology, Shijiazhuang Maternal and Child Health Care Hospital, Shijiazhuang 050000，China; 2.Department of Obstetrics and Gynecology, Baoding Maternal and Child Health Care Hospital, Hebei Baoding 071000，China）
关键词:
子宫内膜癌; 载脂蛋白AI; Apelin; 淋巴脉管间隙浸润
分类号:
R737.33；R730.43
DOI:
10.3969/j.issn.1671-7414.2023.05.010
文献标志码:
A
摘要:
目的 分析子宫内膜癌（endometrial cancer ，EC）患者术前血清载脂蛋白AI（apolipoprotein A1，apo AI）和Apelin 水平检测对预测子宫内膜癌淋巴结脉管间隙浸润（lymph vascular space invasion，LVSI）风险的价值。方法 选取2020 年2 月～ 2022 年6 月石家庄市妇幼保健院97 例EC 患者为研究对象，统计EC 患者LVSI 发生情况并比较不同结果患者的一般资料，采用Logistic 回归分析EC 患者LVSI 风险的影响因素，采用ROC 分析术前血清apo AI 和Apelin水平评估EC患者LVSI 风险的价值，绘制决策曲线分析术前血清apo AI 和Apelin 水平评估EC患者LVSI 风险的净受益率，比较血清apo AI 和Apelin 术前不同表达水平的患者LVSI 发生情况。结果 97 例EC 患者中LVSI 阴性和阳性分别为69例和28 例；Logistic 回归分析显示，肿瘤≥ 2 cm、非子宫内膜样腺癌、低分化、肌层浸润≥ 1/2 和血清Apelin 水平升高是EC 患者LVSI 阳性的独立危险因素，血清apo AI 升高是LVSI 阳性的保护因素（t/χ2=6.592，8.686，4.697，9.098，4.001，2.738 均P ＜ 0.05）；ROC 曲线分析显示术前血清apo AI，Apelin 联合检测评估EC 患者LVSI 风险的AUC 值为0.801，高于二者单独评估的AUC 值（P ＜ 0.001）；决策曲线分析显示当风险阈值为0 ～ 0.55 时，术前血清apo AI，Apelin联合检测的净受益率大于单独检测。结论 术前血清apo AI，Apelin 水平变化对评估EC 患者LVSI 风险具有一定预测价值。低水平apo AI 与高水平Apelin 表明患者LVSI 风险较高。
Abstract:
Objective To analyze the preoperative serum apolipoprotein AI (apo AI) levels in patients with endometrial cancer(EC), and the value of testing Apelin levels in predicting the risk of lymphatic vessel infiltration(LVSI) in endometrial cancer. Methods 97 cases of EC patients in the Shijiazhuang Maternal and Child Health Care Hospital from February 2020 to June 2022 were selected as the study group, and 97 cases of endometrium patients with proliferative stage were selected as the control group. Preoperative serum apo AI and Apelin levels were compared between the two groups, and the results of LVSI in EC patients were statistically analyzed and the general data of patients with different results were compared. Logistic regression was used to analyze the influencing factors of LVSI risk in EC patients, ROC was used to analyze the value of preoperative serum apo AI and Apelin levels in evaluating LVSI risk in EC patients, and a decision curve was drawn to analyze the net benefit rate of preoperative serum apo AI and Apelin levels in evaluating LVSI risk in EC patients. The occurrence of LVSI in patients with different expression levels of serum apo AI and Apelin before operation was compared. Results Among 97 EC patients, 69 cases were negative and 28 cases were positive for LVSI. The pro portion number of LVSI of ≥ 2 cm, non-endometrioid adenocarcinoma, poorly differentiated, and myoinfiltration patients with muscle infiltration ≥ 1/2 in LVSI-positive patients was higher than that in LVSI-negative patients, the preoperative serum apo AI level was lower than that in LVSI-negative patinets, and the Apelin level was higher than that in LVSI-negative patients(t/ χ2=6.592, 8.686, 4.697, 9.098, 4.001, 2.738, all P < 0.05). ROC curve analysis showed that the AUC value of apo AI and Apelin combined preoperative serum in the assessment of LVSI risk in EC patients was 0.801, which was higher than the AUC value of APO AI and APelin alone (P < 0.001). Decision curve analysis showed that when the risk threshold was 0 ~ 0.55, the net benefit rate of preoperative serum apo AI and Apelin combined detection was greater than that of single detection. Conclusion Preoperative changes in serum apo AI and Apelin levels are predictive of LVSI risk in EC patients. Low levels of apo AI and high levels of Apelin indicate high risk of LVSI in EC patients.

参考文献/References:

[1] 赵昌芹, 张瑞林, 廖丽川. 早期子宫内膜癌淋巴脉管间隙浸润与盆腔淋巴结转移的关系及其预后价值[J]. 癌症进展, 2019, 17(18): 2176-2179. ZHAO Changqin, ZHANG Ruilin, LIAO Lichuan. The relationship between lymphovascular space invasion and pelvic lymph node metastasis in early-stage endometrial carcinoma and the prognostic value[J].Oncology Progress, 2019, 17(18): 2176-2179.
[2] 方美丹, 郑群, 袁远. 载脂蛋白A1 与脂蛋白a 在肺癌患者中的诊断价值[J]. 中国卫生检验杂志, 2022,32(1): 19-22, 45. FANG Meidan, ZHENG Qun, YUAN Yuan. Diagnostic value of apolipoprotein A1 and lipoprotein a in lung cancer patients[J]. Chinese Journal of Health Laboratory Technology, 2022, 32(1): 19-22, 45.
[3] 沈静, 杨融辉, 张永超, 等. 载脂蛋白A1 对多发性骨髓瘤预后的影响[J]. 中华血液学杂志, 2020,41(8): 675-679. SHEN Jing, YANG Ronghui, ZHANG Yongchao, et al. The influence of apolipoprotein A1 on the prognosis of multiple myeloma[J]. Chinese Journal of Hematology, 2020, 41(8): 675-679.
[4] CHENG Hai, CHEN Yuhan, LI Xueling, et al. Involvement of apelin/APJ axis in thrombogenesis in valve heart disease patients with atrial fibrillation[J].International Heart Journal, 2019, 60(1): 145-150.
[5] 姚希, 张凯旋. 血清Apelin 和补体C1q 肿瘤坏死因子相关蛋白9 与糖尿病肾病慢性肾脏病Ⅴ期患者血管钙化的关系[J]. 中华实用诊断与治疗杂志, 2020,34(9): 955-958. YAO Xi, ZHANG Kaixuan. Relationships of serum Apelin and CTRP9 with vascular calcification in patients with diabetic nephropathy chronic kidney disease stage- Ⅴ [J]. Journal of Chinese Practical Diagnosis and Therapy, 2020, 34(9): 955-958.
[6] 中国医师协会微无创医学专业委员会妇科肿瘤学组, 中国医院协会妇产医院分会妇科肿瘤专业学组,中国优生科学协会肿瘤生殖学分会. 子宫内膜浆液性癌诊治的中国专家共识(2022 年版)[J]. 癌症进展,2022, 20(9): 865-874, 879. Gynecologic Oncology Group of Minimally Noninvasive Medical Professional Committee of Chinese Medical Doctor Association, Gynecologic Oncology Specialty Group of Obstetrics and Gynecology Hospital Branch of Chinese Hospital Association, Cancer Reproduction Branch of China Healthy Birth Science Association. Chinese expert consensus on the diagnosis and treatment of uterine serous carcinoma(2022 Edition) [J]. Oncology Progress, 2022, 20(9): 865-874, 879.
[7] KLAPDOR R, W?LBER L, HANKER L, et al. Predictive factors for lymph node metastases in vulvar cancer: an analysis of the AGO-CaRE-1 multicenter study[J]. Gynecologic Oncology, 2019, 154(3): 565-570.
[8] 周滢. 早期宫颈癌淋巴脉管间隙浸润与淋巴结转移的关系及其预后价值[J]. 实用妇产科杂志, 2018,34(2): 109-112. ZHOU Ying. The relationship between lymphatic vascular space infiltration and lymph node metastasis in early cervical cancer and its prognostic value[J].Journal of Practical Obstetrics and Gynecology, 2018, 34(2): 109-112.
[9] RESTAINO S, TORTORELLA L, DINOI G, et al. Semiquantitative evaluation of lymph-vascular space invasion in patients affected by endometrial cancer: Prognostic and clinical implications [J]. European Journal of Cancer, 2021, 142: 29-37.
[10] 李功娟, 张治洋, 樊阳阳. FEZF1-AS1 在子宫内膜癌中的表达及其与患者临床特征的相关性[J]. 现代检验医学杂志, 2021, 36(1): 77-80. LI Gongjuan, ZHANG Zhiyang, FAN Yangyang. Expression of FEZF1-AS1 in endometrial carcinoma and its correlation with clinical characteristics of patients[J]. Journal of Modern Laboratory Medicine, 2021, 36(1): 77-80.
[11] 林颖欣, 张月华, 张淦梅, 等. 免疫组化联合半定量法检测淋巴脉管间隙浸润在早期子宫内膜癌的预后价值[J]. 陆军军医大学学报, 2022, 44(13): 1370-1377. LIN Yingxin, ZHANG Yuehua, ZHANG Ganmei, et al. Prognostic value of lymphovascular space invasion evaluated by immunohistochemistry and stratification with a semi-quantitative scoring system for earlystage endometrial cancer [J]. Journal of Third Military Medical University, 2022, 44(13): 1370-1377.
[12] RICHART A L, REDDY M, KHALAJI M, et al. Apo AI nanoparticles delivered post myocardial infarction moderate inflammation [J]. Circ Res, 2020, 127(11):1422-1436.
[13] 闫伟, 霍方杰, 戴雪娥. 小细胞肺癌患者Apo-E,ApoC- Ⅲ和NSE 水平测定和临床意义[J]. 中国肿瘤临床与康复, 2019, 26(8): 915-919. YAN Wei, HUO Fangjie, DAI Xue’e. Determination of Apo-E,ApoC- Ⅲ and NSE levels in patients with small cell lung cancer and its clinical significance [J]. Chinese Journal of Clinical Oncology and Rehabilitation, 2019, 26(8): 915-919.
[14] SUH Y, AFAQ F, JOHNSON J J, et al. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaBsignaling pathways[J]. Carcinogenesis, 2009, 30(2): 300-307.
[15] SMITH R C, BULANADI J C, GILL A J, et al. Pancreatic adenocarcinoma preferentially takes up and is suppressed by synthetic nanoparticles carrying apolipoprotein A-II and a lipid gemcitabine prodrug in mice [J]. Cancer Letters, 2020, 495: 112-122.
[16] ZHANG Hangyu, WANG Yongfang, LIU Changgang, et al. The apolipoprotein C1 is involved in breast cancer progression via EMT and MAPK/JNK pathway [J].Pathology Research and Practice, 2022, 229: 153746.
[17] 张之梁, 任华, 马燕, 等. 老年颈动脉硬化患者血清Vaspin, Apelin, Omentin-1 水平与糖脂代谢及骨密度的关系[J]. 疑难病杂志, 2020, 19(11): 1097-1101. ZHANG Zhiliang, REN Hua, MA Yan, et al. The relationship between serum Vaspin, Apelin, Omentin-1 levels and glucose and lipid metabolism and bone mineral density in elderly patients with carotid atherosclerosis [J]. Chinese Journal of Difficult and Complicated Cases, 2020, 19(11): 1097-1101.
[18] 张建平, 林文静, 石银华, 等. H 型高血压合并急性缺血性脑卒中患者血清Apelin-13, Irisin 水平变化及意义[J]. 山东医药, 2021, 61(7): 1-5. ZHANG Jianping, LIN Wenjing, SHI Yinhua, et al. Changes of serum Apelin-13 and Irisin levels in patients with H-type hypertension combined with acute ischemic stroke and their clinical significance [J].Shandong Medical Journal, 2021, 61(7): 1-5.
[19] 白翠林, 贾李侠, 李宁, 等. 老年肺炎患者血清Apelin-13 水平与疾病严重程度和预后的相关性研究[J]. 现代生物医学进展, 2021, 21(23): 4554-4558. BAI Cuilin, JIA Lixia, LI Ning, et al. Study on the correlation between serum Apelin-13 level and disease severity and prognosis in elderly patients with pneumonia[J]. Progress in Modern Biomedicine, 2021, 21(23): 4554-4558.

相似文献/References:

[1]李 玲a,罗雅文a,何 霞a,等.子宫内膜癌患者BMI与血清HE4,CA125联合检测的诊断价值[J].现代检验医学杂志,2018,33(05):91.[doi:10.3969/j.issn.1671-7414.2018.05.024]
　LI Linga,LUO Ya-wena,HE Xiaa,et al.Diagnostic Value of Combined Detection of Body Mass Index and Serum HE4,CA125 in Patients with Endometrial Carcinoma[J].Journal of Modern Laboratory Medicine,2018,33(05):91.[doi:10.3969/j.issn.1671-7414.2018.05.024]
[2]李晓丽,胡陇娟.子宫内膜癌组织中长链非编码RNA ZEB1-AS1的表达与临床特征及对化疗药物耐药性研究[J].现代检验医学杂志,2019,34(04):35.[doi:10.3969/j.issn.1671-7414.2019.04.009]
　LI Xiao-li,HU Long-juan.Research on Expression and Clinical Characteristics of Long-Chain Non-Coding RNA ZEB1-AS1 in Endometrial Carcinoma and Resistance to Chemotherapy Drugs[J].Journal of Modern Laboratory Medicine,2019,34(05):35.[doi:10.3969/j.issn.1671-7414.2019.04.009]
[3]王娟,刘鑫,席稳燕.HMMR-AS1 在子宫内膜癌化疗耐药中的作用[J].现代检验医学杂志,2020,35(05):45.[doi:10.3969/j.issn.1671-7414.2020.05.012]
　WANG Juan,LIU Xin,XI Wen-yan.Effect of HMMR-AS1 on the Chemotherapy-Resistance of Endometrial Cancer[J].Journal of Modern Laboratory Medicine,2020,35(05):45.[doi:10.3969/j.issn.1671-7414.2020.05.012]
[4]李功娟,张治洋,樊阳阳.FEZF1-AS1在子宫内膜癌中的表达及其与患者临床特征的相关性[J].现代检验医学杂志,2021,36(01):77.[doi:10.3969/j.issn.1671-7414.2021.01.020]
　LI Gong-juan,ZHANG Zhi-yang,FAN Yang-yang.Expression of FEZF1-AS1 in Endometrial Carcinoma and Its Correlation with Clinical Characteristics of Patients[J].Journal of Modern Laboratory Medicine,2021,36(05):77.[doi:10.3969/j.issn.1671-7414.2021.01.020]
[5]陈丽华,朱婕曼,刘玉凤,等.子宫内膜癌组织中血管紧张素~1-7及线粒体组装受体水平表达与临床病理特征的相关性[J].现代检验医学杂志,2021,36(02):24.[doi:doi:10.3969/j.issn.1671-7414.2021.02.006]
　CHEN Li-hua,ZHU Jie-man,LIU Yu-feng,et al.Correlation between the Expression of Angiotensin (1-7) and Mitochondrial Assembled Receptors and Clinicopathological Characteristics in Endometrial Cancer[J].Journal of Modern Laboratory Medicine,2021,36(05):24.[doi:doi:10.3969/j.issn.1671-7414.2021.02.006]
[6]陈晓宇,曾庆维,陈红林,等.子宫内膜癌组织中miR-3188和mTOR表达量与预后的相关性研究[J].现代检验医学杂志,2021,36(06):17.[doi:10.3969/j.issn.1671-7414.2021.06.004]
　CHEN Xiao-yu,ZENG Qing-wei,CHEN Hong-lin,et al.Study on the Correlation between the Expression Levels of miR-3188 and mTOR in Endometrial Cancer and the Prognosis[J].Journal of Modern Laboratory Medicine,2021,36(05):17.[doi:10.3969/j.issn.1671-7414.2021.06.004]
[7]刘静雅,张海亮,李宝平,等.长链非编码 RNA SNHG1在子宫内膜癌中的表达及调控 PI3K/AKT信号通路的研究[J].现代检验医学杂志,2022,37(01):119.[doi:10.3969/j.issn.1671-7414.2022.01.024]
　LIU Jing-ya,ZHANG Hai-liang,LI Bao-ping,et al.Expression of Long Non-coding RNA SNHG1 in Endometrial Carcinoma and Its Regulation of PI3K/AKT Signaling Pathway[J].Journal of Modern Laboratory Medicine,2022,37(05):119.[doi:10.3969/j.issn.1671-7414.2022.01.024]
[8]彭 浩,张印星,谢 环.长链非编码RNA CDKN2BAS 在子宫内膜癌组织表达及其生物学功能研究[J].现代检验医学杂志,2023,38(03):92.[doi:10.3969/j.issn.1671-7414.2023.03.016]
　PENG Hao,ZHANG Yin-xing,XIE Huan.Expression and Biological Function of Long Non-coding RNA CDKN2BAS in Endometrial Carcinoma[J].Journal of Modern Laboratory Medicine,2023,38(05):92.[doi:10.3969/j.issn.1671-7414.2023.03.016]
[9]陆 瑞,郭红霞,吴苗苗,等.KIF18B 通过激活Wnt/β catenin 信号通路促进子宫内膜癌细胞增殖和转移的实验研究[J].现代检验医学杂志,2023,38(05):58.[doi:10.3969/j.issn.1671-7414.2023.05.011]
　LU Rui,GUO Hongxia,WU Miaomiao,et al.Experimental Study of KIF18B Promoting Endometrial Cancer Cell Proliferation and Metastasis by Activating Wnt/β-catenin Signaling Pathway[J].Journal of Modern Laboratory Medicine,2023,38(05):58.[doi:10.3969/j.issn.1671-7414.2023.05.011]
[10]柴 静,张家弘,李梦雪.子宫内膜癌组织中TMIGD2，TIGIT 的表达及其与临床病理特征的相关性研究[J].现代检验医学杂志,2023,38(06):87.[doi:10.3969/j.issn.1671-7414.2023.06.016]
　CHAI Jing,ZHANG Jiahong,LI Mengxue.Expression of TMIGD2 and TIGIT in Endometrial Cancer Tissue and Their Correlation with Clinical Pathological Features[J].Journal of Modern Laboratory Medicine,2023,38(05):87.[doi:10.3969/j.issn.1671-7414.2023.06.016]

备注/Memo

备注/Memo:
基金项目：河北省医学科学研究课题计划项目（20200277）：术前血清因子预测子宫内膜癌LVSI 风险的价值研究。
作者简介：梁燕茹（1987-），女，大学本科，主治医师，研究方向：子宫内膜癌的诊治工作，E-mail：liangyanru87@sina.com。
更新日期/Last Update: 2023-09-15